DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 201 filers reported holding DEPOMED INC in Q1 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $891,000 | +7.2% | 132,325 | +4.9% | 0.00% | 0.0% |
| Q1 2018 | $831,000 | -15.9% | 126,154 | +3.0% | 0.00% | 0.0% |
| Q4 2017 | $988,000 | +42.4% | 122,517 | +2.2% | 0.00% | 0.0% |
| Q3 2017 | $694,000 | -45.8% | 119,867 | +0.5% | 0.00% | 0.0% |
| Q2 2017 | $1,280,000 | -7.9% | 119,225 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $1,390,000 | -29.7% | 110,642 | +0.7% | 0.00% | -50.0% |
| Q4 2016 | $1,977,000 | +36.6% | 109,881 | +88.5% | 0.00% | +100.0% |
| Q3 2016 | $1,447,000 | +402.4% | 58,305 | +285.9% | 0.00% | – |
| Q2 2016 | $288,000 | +36.5% | 15,110 | 0.0% | 0.00% | – |
| Q1 2016 | $211,000 | -2.3% | 15,110 | +29.3% | 0.00% | – |
| Q4 2015 | $216,000 | +9.6% | 11,687 | 0.0% | 0.00% | – |
| Q3 2015 | $197,000 | +7.1% | 11,687 | +32.7% | 0.00% | – |
| Q2 2015 | $184,000 | -8.0% | 8,807 | 0.0% | 0.00% | – |
| Q1 2015 | $200,000 | +41.8% | 8,807 | 0.0% | 0.00% | – |
| Q4 2014 | $141,000 | +6.0% | 8,807 | 0.0% | 0.00% | – |
| Q3 2014 | $133,000 | – | 8,807 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |